UNSPSC 51152403: Aspirin/carisoprodol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS200. This VA Drug Class (MS200) classifies this compound as belonging to the group SKELETAL MUSCLE RELAXANTS.

UNSPSC 51152403 Aspirin/carisoprodol is a Commodity code that in recent state and local procurement shows minimal alignment with its nominal scope — the recent opportunities tagged to this code involve naloxone, drug deactivation systems, and direct-to-manufacturer prescription programs, none of which are aspirin or muscle relaxant products. Seminole County, Florida solicited naloxone and safe drug deactivation systems through an IFB (Solicitation IFB60459723LAS, due July 26, 2023), and the Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer prescription fulfillment capabilities (RFI HHS0017013, response deadline April 3, 2026). The code shows little relevant recent activity tied to the pharmaceutical products it nominally describes; the opportunities posted under it appear to reflect either data-entry misclassification or a divergence between the code's intended scope and how state and local procurement offices are currently tagging pharmaceutical and health-support acquisitions.

The geographic spread of recent activity is limited to Florida and Texas, with no additional jurisdictions represented in the posted opportunities. Issuing bodies include a county health department (Seminole County) and a state health and human services agency (Texas HHS Commission). Without substantive recent opportunities that actually match aspirin/carisoprodol scope, this code does not present a clear buying pattern or procurement momentum for vendors targeting muscle relaxant or over-the-counter analgesic products through state and local channels. Firms should verify classification accuracy with issuing bodies before pursuing opportunities tagged to this code.